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Determination of etylendioxid IgE antibodies in a group of patients on
hemodialysis. S. KarI,sson, K. Skogstrom, Dialvsi,s Unit, Department of
Internal Medicine, Medical Center Hospital Orebro, Simeden. Thirty—
seven patients were included in the investigation. They were divided in
groups depending on type of membrane. These groups were divided in
subgroups according to how long the patients have been on dialysis
treatment. S-lgE antibodies were determined by RAST-method, with a
positive test of <2.0. As a routine the membranes and blood lines were
rinsed with 2.0 liter NaCI before the beginning of the dialysis. This
procedure has been standard for over a year. Only one patient had a
positive RAST-test, but he had no allergic symptoms. 1-Ic was on
dialysis with a cuprophan membrane. Another patient who earlier had
an anafylactoid reaction during dialysis did not have a positive RAST-
test. No significant difference between the groups (euprophan-
gambrane and CA-EVA membranes) was noticed: x was 1.06 in the
cuprophan-gambrane group (when the patient with positive RAST test
was excluded). X was 1.04 in the CA-EVA group. There was no
difference between the subgroups in IgE antibodies level, that is to say.
patients with dialysis <0.5 years: >0.5 < 2 years: >2 < 5 years: >5
years. No patient except the one earlier mentioned had a titer above
2.0. It seems as if the risk of aquiring high levels of igE antibodies and
thus allergic reactions is not as great at earlier suspected. Perhaps the
storing time reduces the amount of etylendioxid. Maybe it is possible to
reduce the amount of NaCl that the membranes and blood lines are
rinsed with.
Small doses of calcitriol suppress secondary hyperparathyroidsm (sec
HPT) and do not harm renal function in patients with chronic renal
failure (CRF). K. P. Nordal, E. Do/il, J. Ha/se, Medical and Surgical
Departments, National Hospital, Rikshospita/et, Oslo, Norway. Thirty
patients (10 women), aged 23—71 (mean: 47) years svith moderate CRF(Sr 347 196. mean so .tmol/liter) and evidence of stable renal
function over the previous 4 months, participated in a double blind.
randomized study, receiving either calcitriol or placebo for eight
months. Age and diagnosis were similar in the two groups. Bone
biopsies after double labeling with tetracycline was obtained at start arid
end. The patients were controlled at least monthly. Maximum daily
calcitriol dose was set at 0.50 rg. If S<, levels reached more than 2.6
mmol/liter. treatment was suspended for 3 days and then adjusted to
maintain S. between 2.4 and 2.7 mmol/liter. Serum P was kept at less
than 1.8 mmol/liter using Al-containing phosphate binder. There was no
significant difference in biochemical parameters or histomorphometric
bone parameters at the start. From the second month on S. and ion Ca
increased (P < 0.01). ALP, PTH and urinary cAMP decreased (P <
0.01). The calcitriol dose was reduced on 17 occasions in 8 patients due
to hypercalcemia. Mean daily dose was 0.34 rg. Calcitriol treatment led
to significantly lower values of all bone parameters, except fractional
trabebecular bone volume, fractional doubled-labeled surfaces and
mineralization lag time. 5C. increased during the study period in both
groups, but there was no significant difference between the two groups
at any time. Conclusion: Calcitriol treatment using low dosage suppress
the see. HPT and is a safe way to preserve or restore bone metabolism
in patients with moderate CRF. If hypercalcemia is avoided, no
deleterious effect on renal function is seen.
Acute hemodynamic changes in the passive heymann nephritis (PHN) is
mediated by the complement system via the anaphylatoxin CSA. I. Sekse,
B. Ill. Iversen, M. R. Do/ia, J. Ofitad. Med. Department A, University
of Bergc'n, Norway, and Department of Nephrologv, Unim'ers,tv f
Leiden. The Netherlands. PHN in rats is induced by infusion of
antibodies towards renal tubular brushborder antigens (anti-FxIA); the
course of the diseae is dose dependent. Our hypothesis is that RBF and
GFR changes in the acute phase influence the progression of the
disease. We have therefore studied changes in RBF (flow probe) and
GFR (lothalamat clearance) during the first hour after infusion of
anti-FxIA antibodies into the left renal artery and compared the results
with those obtained after infusion of non-complement fixing F(ab')2
antibodies or C5a complement fraction. RBF and GFR measured 40 to
50mm (left kidney) after start of the different infusions are shown in the
Table; each group is compared with its own control group. The results
are expressed in ml/min/g kidney weight (mean I SEM). The blood
pressure was not different in experimental (exp) and control (ctr)
groups.
RBF GFR
exp etr P exp ctr P
AFxIA 3.3 0.7 6.1 1.0 <0.05 0.2 0.1 0.5 0.1 <0.02
F(ab) 6.0 0.5 7.6 0.9 NS 1.1 0.1 0.8 0.1 NS
C5a 3.7 0.5 7.0 0.8 <0.01 0.5 0.1 0.6 0.1 NS
The results demonstrate that theme is an acute vasoconstriction and a
fall in GFR during the first hour of antibody infusion. This is abolished
when non-complement fixing fraction of AfxlA F (ab')2 is injected. but
the phenomenon reappears after infusion of complement C5a. Activa-
tion of the terminal complement cascade may provoke the renal
vasoconstriction. A fall in filtration coefficient may explain the reduced
GFR.
fJ2-Microglobulin in a group of hemodialysis patients. S. Ko,'ls.son, K.
.Skogstrom, Dialysis Unit, Dept. of Internal Medicine. Medical Center
Hospital Orebro, Sweden. The investigation was started to follow the
change in -M levels in a group of heniodialysis patients according to
type of dialysis, type of membranes, duration of hemodialysis treatment
and symptoms, such as carpal tunnel syndrome (CTS). S-[3-M was
taken before and after dialysis and repeated again in connection with
change of membrane, change of dialysis method. S-ft-M was deter-
mined with RIA-method. The patients have also answered a question-
naire, especially regarding symptoms such as CTS. The motor conduc-
tion in the median nerve was determined. The investigation included 21
patients. Twenty-one patients had cuprophan membranes. They
showed an increase of postdialysis S-p2-M with 21.1% (from 44-53.3
mg/liter). The increase of postdialysis S--M in 7 patients with CA-
membranes was 15.7% (from 48.4-56). No certain change in postdialysis
S-f3-M was seen in the small groups treated with gambrane and
EVA-membranes (2 patients in each group). The investigation shows
that the longer the patients have been on dialysis the higher predialysis
S-p-M valves were found (<0.5 years, 32.3; >0.5 years <2 years, 43.3:
>2 years <5 years. 46.1: >5 years 53 mg/liter). The rise in postdialysis
in S-2-M was also greater in patients with longer dialysis treatment
(<0.5 years 4.2%: >0.5 years < 2 years 15.7%; > 2 years < 5 years
19.3%: < 5 years 25%). Seventeen of the 32 patients answered the
questionnaire. Nine patients had symptoms of compression of the
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median nerve and 7 had a considerable delay in motor conduction.
There is a difference in 2-M level depending on the time of dialysis and
type of dialysis method. The investigation will continue to see if the
S-,-M level can be used to decide what kind of membrane and type of
dialysis method should be used on different types of patients.
Acute renal failure (ARF) requiring dialysis. Einar M. Berg, Vidar
Arnulf, RoIfDigre, Tar WiderØe, Regional Hospital, Trondheim, Nor-
way. We retrospectively examined the records of patients with ARF
requiring dialysis in the period of 1975—85. Sex, age, cause of ARF,
mode of presentation of ARF, type of dialysis and mortality was
obtained. Results. Ninety-four patients were included: 30 females,
mean age 49 years (range 3-80), 64 males, mean age 51 years (range
8-84). The renal cause of ARF (N = 79) had a mortality of 44.4%. The
prerenal cause of ARF (N = 6) had a mortality of 50%. and the mortality
was 11.1% in patients with postrenal cause of ARF (N = 9). ARF with
non-oliguric presentation (N = 9) had a mortality of 22.2%; the oliguric
presentation (N = 46) had a mortality of 39.1%, and the anuric
presentation (N = 39) had a mortality of 48.7%. ARF caused by sepsis
(N 22) had a mortality of 63.6%. Postoperative ARF (N = 16) had a
mortality of 62.5%. The mortality was 13.3% in ARF caused by
glomerulonephritis (N = IS). Eighty-two percent of the patients (N =
77) were treated with hemodialysis, 18% (N = 17) with peritoneal
dialysis. Patients who regained satisfactory renal function had a mean
dialyzing time of 12 days; 9 days in patients who died. The non-oliguric
patients had a mean dialyzing time of 27 days, the oliguric 12 days and
anuric 7 days. Patients below 50 years of age (N 32) had a mortality
of 34.4%, patients 50 to 70 years had a mortality of 45.5%, over 70 years
the mortality was 44.4%. Outcome of the study: 12.8% remained in
permanent dialysis (N = 12), 45.7% regained satisfactory renal function(N = 43), 4 1.5% died (N 39). Conclusion. The mortality of patients
with ARF is generally high. The highest mortality rates were seen when
ARF developed postoperatively (62.5%) and/or during sepsis (63.6%).
Bone mineral content (BMC) in kidney transplanted patients (PTS).
Time for treatment? B. Lindergard, J. Kurkus, University Hospital,
Department of Nephrology, Lund, 5-22/ 85 Sweden. First-time trans-
planted pts, 119 during 1972—1983, were followed with BMC measure-
ments, routinely performed on the cortical bone of the forearms, using
a single photon absorption technique. We excluded pts <20 yrs of age,
pts with rheumatoid arthritis and malignant diseases. BMC decreased in
93 non-diabetic pts by on average 1.4 %/yr and in 26 diabetic pts by 0.5
%/yr. In age-matched (<45 yrs) non-diabetics the BMC decreased by
0.6 %/yr compared to diabetics who decreased by 0.03 %/yr (N.S.).
BMC in pts with s-creatinine >150 mol/liter decreased significantly
faster than in pts with better kidney function. In men there were no
correlations between age and decrease in BMC whereas the BMC
decreased faster in older women than in younger. In 9 of II women >45
yrs of age at transplantation and followed >4 yrs, the BMC decreased
as individually significant straight lines with 1 to 5 %/yr. We feel it
important to identify the fast bone mineral loosing pt because preven-
tive trials may be necessary, especially as these patients have low bone
mineral content already at the time of transplantation.
Red cell and serum folate levels in dialysis patients. B. Kron, K.
SkogstrOm, Depart,neni of Medicine, Medical Center Hospital,
Orebro, Sweden. Folate supplementations (5 mg/day) were withdrawn
in a group of 34 patients (A). B- and S-Folate and different hematolog-
ical parameters (Hb, MCV, MCHC,EVF) were analyzed before, three
and six months after the withdrawal. Another group of 7 dialysis
patients (B) were never supplemented. They were observed in the same
way. Results. Before withdrawal the B-Folate levels for 28 patients in
group A were so high that only ">-values" were obtained in spite of
many dilution steps. There is no doubt that these patients accumulated
folic acid. The B-Folate mean for the remaining 6 patients in group A
was 3018 nmol/liter (normal range 280-1360). The mean after 3 months
was 1991 and after 6 months 1192. The mean for S-Folate before, three
and six months after withdrawal was 155, 69 and 22 nmol/liter,
respectively (normal range 7-34). The patients in group B have had
normal red cell and serum folate levels during the study. There are no
significant changes in the hematological parameters in neither of the
groups during the study. Conclusions. Folate supplementation (5
mg/day) give rise to excessive accumulation of folic acid and may thus
be questioned. There were no subnormal levels of folic acid and no
changes in the hematological parameters after the withdrawal of folate
supplementation.
Complement activation in plasma exchange (PE): Filters compared to
centrifugation. B. G. Stegmayr, A. Thrnvik, L. Korlsson, B. Lindqvist,
Departments of Nephrology & Clinical Bacteriology, University Hos-
pital, Umeil, Sweden. Dialysis by filtration technique has been sug-
gested to cause activation of plasma complement. We have applied an
assay of C3d, a split product of complement component C3, to estimate
complement activation during plasma exchange (PE) induced by cen-
trifugation- as compared to filtration-technique. C3d was assayed by
electro-immunoassay of plasma samples obtained before and after PE
from 13 patients in 31 exchanges. Upon PE by single filter (SF; N = 7)
and centrifugation (C; N = 9) 2000-3000 ml plasma was exchanged 1:1
by 5% albumin. The patients' mean C3d values were lowered after PE
by SF (11.7-5.4 mU/liter) and C (6.8-4.3), and significantly increased
after double filtration (DF; N = IS) from 20.2 to 49.8 mU/liter (t =
—4.82, P < 0.001). In the waste plasma there was no C3d with C while
the amounts recovered did not differ significantly for SF (mean 81 SD 5
mU/PE) and DF (mean 113, SD = 42 mU/PE). In this study side effects
were seen in 3 of IS PE's by the use of DF but not by C or SF. The
results indicate that, for plasma exchange, centrifugation may be less
afflicted with complement activation than is filtration.
HIV antibodies in Danish dialysis patients. G. Schmidt, B. Nielsen, B.
Lindhardt, Danish Society of Nephrology and The Fihiger Institute,
Copenhagen, Denmark. Among 708 Danish patients on regular dialysis
treatment (RDT) in 1986 one patient was found seropositive for anti-
body to human immunodeficiency virus (HIV): a 62-year-old woman
who had received hemodialysis for 7 years, had received 125 units of
blood, did not belong to the known AIDS risk groups, and who died
shortly after the investigation from cardiac failure with no signs of
infection. In a further 39 patients the ELISA test was found to be
positive while Western blot and immune fluorescence test were nega-
tive. A significant correlation between the presence of this 'false
positive" reaction by ELISA test and previous kidney transplantation,
individual number of blood transfusions, and the demonstration of
lymphocytotoxic antibodies was found. Renal diagnosis, age, sex, time
on RDT, type of treatment, previous or ongoing infections, travel
activity, serum creatinine level, peripheral lymphocyte count, and
tissue type showed no correlation to the false positive ELISA test. No
patients had AIDS or AIDS-related syndromes, and no patients admit-
ted to be homo- or bisexual.
Skeletal lesions caused by beta2-microglobulin amyloidosis in a patient
on chronic hemodialysis. K. Dc/in, P-O. Attinan, B.F.F. Zachrisson, 0.
Berlin, J. Wilske, C. Ss'alander, Departments of Nephrology, Radiol-
ogy, Orihopuedic Surger' and Pathology. University of Gäteborg,
Goteborg, Sweden. A 70-year-old woman with ESRD following neph-
rocalcinosis had been treated with hemodialysis for 5 years when she
was operated for a bilateral carpal tunnel syndrome. Two years later
she developed pain in the left hip and radiograms revealed an osteolytic
lesion in the femoral neck. incisional biopsy excluded the possibility of
a malignant tumor. The lesion was curetted and filled with autologous
bone transplant, and healing was uneventful. Light microscopy showed
amorphous tissue with few cells, amyloid was demonstrated by a
positive alkaline Kongo stain with green dicroism in polarised light.
-microgIobulin was demonstrated with the ABC immuno-histochem-
ical method. After her death from a myocardial infarction, amyloid
could not be demonstrated in vertebral bone, myocardium, liver or
renal tissue. This new form of amyloidosis has only recently been
recognized as a comlication to chronic hemodialysis. The amyloid is
found in synovial tissue and bone and the most common clinical
manifestation is a carpal tunnel syndrome. An osteolytic lesion, as
found in our patient, has been described in a limited number of cases.
The amyloid contains p2-microglobulin, a normal constituent of plasma
that is almost exclusively eliminated by glomerular filtration but not by
conventional hemodialysis, which even appears to increase its release
to plasma. in order to prevent amyloid formation measures that affect
turnover, deposition and elimination of the p2-microglobulin are cur-
rently being studied.
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Renal reactions to acute inhibition of converting enzyme in renovascu-
lar patients. K. Dc/in, G. Granerus, R. Vo/k,nann, M. Aurell, Depart-
mc'nts of Nephrologv and Clinical Physiology, Unirersitv qfGotehorg,
Gdtehorg, Sweden. Renin release can be stimulated by converting
enzyme inhibition (CEI). This also interferes with renal autoregulation
of GFR in a low-pressure perfused kidney. The reactions were studied
by renal vein catheterization in 22 patients, and 13 have been
revascularized with effect on BP. Samples were taken before and
30-minutes after 1.25 mg enalaprilat i.v. Changes in split renal function
were measured by gammacamera renography in 12 patients. Means and
SEM are given. BP fell from 172 7/91 3 to 139 6/72 3 mm Hg.
CE fell from 43 4 to 0.2 0.04 units. Arterial renin levels rose from
5.7 1.1 to 23.3 5.1 ng Al/mi/hr or 4.2 0.5 times. Renal V/A renin
ratios increased from 1.4 0.01 to 3.6 1.1 on the stenotic side, and
remained near unity on the contralateral one: 1.0 0.04 and 1.2 0.06.
Extraction ratios (%) for PAH were 75.6 5.0 and 89.7 1.3 on the
stenotic and contralateral sides, respectively, and remained unaffected
by ACEL. Extraction ratios (%) for 51Cr-EDTA, reflecting filtration
fractions, fell from 13.3 1.3 to 8.4 1.6 and from 19.5 0.9 to 15.0
1.0 on stenotic and contralateral sides, respectively. GFR fell 5 5
ml (range —18 to 36) from 29 5 mI/mm to 24 6 on the involved side
and rose 6 4 (range —20 to 30) from 47 4 to 53 7 on the
contralateral one. The filtration fraction is typically low in the involved
kidney. ACEI enhances lateralization of renin secretion. Changes in the
gammacamera renogram and the filtration fraction after ACE! is infor-
mative in cases where autoregulation maintains normal function in the
involved kidney.
Renal function in the transplanted kidney and the remaining donor
kidney after living donor transplantation. Adaptation of the adult kidney
to the juvenile recipient. A. Bob/in, U. Berg, Department sf Pediatrics,
Karol/oslo, Institute, Huddinge 1-Jospital, Stock/jo/mn, Sueden. Renal
function was evaluated in 9 transplanted children aged 1.3—11.8 years,
and 9 adult kidney donors, 34—61 years old. Twelve individuals were
paired donor-recipients. The remaining three children had received
cadaveric kidneys, and the remaining three adults had donated kidneys.
that stopped functioning. The glomerular filtration rate (GFR) and
effective renal plasma flow (ERPF) were determined as the clearances
of nulin and PAH. respectively. Inulin and PAN were given as a
continuous infusion after a prime dose. Water diuresis was induced to
enable urine sampling by spontaneous voiding. Results. The GFR and
ERPF of the donors were approximately twice as high (68 7 and 366
38 mI/mm resp.) as those of the recipients (36 II and 202 53
mI/mm resp.). Related to body surface area, however, the GFR and
ERPF of therecipients (79 20 and 440 76 mI/mm/I .73 m2 resp.) were
significantly higher than those of the donors (63 6 and 338 42
ml/min/I.73m 2 resp.) The serum creatinine concentration was signifi-
cantly higher in the donors. 109 14 cmol/liter than in the recipients,
62 22 imol/liter. which could be explained by the differences in body
mass. The serum urea concentration of the recipients, 9.6 3.0
mmol/liter was significantly higher than that of the donors,.9 + 0.7
mmol/liter. It is concluded that transplantation of an adult kidney to a
child results in adaptation of renal function to the small body size of the
recipient.
Continuous arteriovenous hemofiltration (CAVH) for treatment of
acute renal failure (ARF) in critically ill patients. A report of 100 patients.
L. Weiss, B. G. Dauuje/son, B. Fe//strom, G. Tuifueson, B. Wikstrd,n,
Departments of Inieriwl Medicine and Urolog', University Hospital,
Uppsa/a, Swede,,. In our experience peritoneal dialysis and hemodial-
ysis is of limited value as treatment of ARF in critically ill patients with
multiorgan failure. In 1982 we therefore introduced CAVH as treatment
of ARF in this category of patients. This is a report of outcome and
clinical experience of the first 100 patients. Material and ,neihods. The
causes of ARF were complications to cardiac surgery (26), complica-
tions to aortic surgery (24), septicemia (16). complications to abdominal
surgery (8). major burns (8). multiple trauma (5), rhabdomyolysis (3)
and miscellaneous (10). The mean age was 55 years (range 13-84). All
patients had other complications beside their ARF, i.e. respiratory
insufficiency with a need for artificial ventilation, a need for vasopressor
infusions and some even needed aortic balloon pumps to maintain
systolic blood pressure. Patients with uncomplicated ARF were not
treated with CAVH hut had intermittent dialysis. Results. CAVH was
maintained from 1-88 days (mean II days). The survival rate was 45%
and only 3 patients were transferred to regular dialysis. Good uremic
control was achieved when the treatment was started early in the course
of uremia. A major improvement was the possibility to give adequate
nutritional support even to anuric hypercatabolic patients. Conclusions.
CAVH is an efficient treatment in critically ill patients with ARF. We
therefore suggest that CAVH should be the first choice treatment in this
type of patients.
Progressive decrease of serum albumin in patients undergoing long.
term CAPD. B. Lindhol,n, A. Tranaeu.s, J. Bergstrom, Dept. of Renal
Medicine, Karolinska Institute, Huddinge University Hospital, Stock-
holm, Sweden. Long-term follow-up studies on biochemical data in
large CAPD populations are lacking and statistically significant long-
term trends have therefore seldom been established. In this study, all
available serum biochemistry data in 121 consecutive adult patients
starting on CAPD between 1978 and 1984 were evaluated:
Months on
CAPD: 3(N= 96) l2(N=67) 24(N=38) 36(N 25)
Body weight 63.6 10.7 65.6± 1I.3 65.7 ll.4 65.3 l0.4
kg
Albumin 36.9 5.3 37.6 6.! 37.3 5.7 34.8 6.7k
gilder
Triglycerides 3.1 1.9 3.7 3.5 3.5 4.9 3.2 3.3
mmol/liter
Cholesterol 6.9 1.9 7.0 21h 7.0 2.1 6.7 2.0
mm oh/liter
Creatinine 905 262 1043 279C 1059 258 1108 249C
jzmol/liter
Urea 21.0 5.7 21.5 6.3 21.0 6.2 21.5 7.6
mmol/liter
Mean so, P < oo5, hp < 0.01, CP < 0.001, Students' paired t-test,
compared to 3 months.
Body weight, triglycerides, cholesterol, and creatinine increased
significantly during the first year on CAPD whereas serum urea re-
mained stable. After an initial significant rise in serum albumin (A) at 3
months (m) there was a progressive decrease in A which was significant
at 36, 48 and 60 m. At 36 m, 48% of the patients had A<35 g/liter and
20% had A<30 g/liter. A correlated with: creatinine at 3. 12, 24, 36 and
60 m; urea at 36 and 48 m; cholesterol at 6 and 12 m; and, body weight
at 36 m. This study shows that a major part of long-term CAPD patients
have subnormal A levels indicating protein malnutrition. The correla-
tion between A and cholesterol indicates that the initial rise of choles-
terol during CAPD may reflect improved nutrition. Overall these results
suggest that A can provide a rough estimate of protein malnutrition in
CAPD.
Prospective study of renal hemodynamics in insulin-dependent diabetes
mellitus with onset during childhood. U. Berg, B. Thalmne, Department
of Pediatrics, Huddinge University Hospital, Huddinge, Sueden.
Around 40% of patients with insulin-dependent diabetes mellitus
(IDDM) will develop diabetic nephropathy. It has been proposed that
early renal functional changes might predict the development of dia-
betic nephropathy. why the aim of the present study was to perform a
prospective long-term follow-up of renal function in IDDM in children.
One hundred and twenty-four children. 1.5—16 years of age at onset of
disease, were followed regularly by renal function and metabolic
control. Follow-up time varied between 2 and 10 years. Glomerular
filtration rate (GFR) and effective renal plasma flow (ERPF) were
determined by clearances of inulin and PAH during water diuresis.
Renal function tests were performed at onset, after 2.5 and 10 years.
Metabolic control was evaluated on the basis of home controls of blood
and urine glucose determinations as well as determination of HbA,. The
patients were divided in those with good and bad metabolic control as
well as according to ages at onset <4yr, 4-8 yr. 8-12 yr, and 12-16 years.
Patients in good control dominated during the first two years of the
disease while after 5 and 10 years increasing numbers of patients were
in bad metabolic control. GFR was significantly increased with mean
values between 131 and 145 ml/min/l.73 m2 in different age groups at
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onset. ERPF did not differ from that of controls. No significant change
in GFR was seen during follow-up in patients with onset before the age
of 8 years. In patients with onset after the age of 8 years a significant
increase in GFR was seen from onset to 2 years duration while a
significant decrease in GFR was seen between S and 10 years duration.
After 5 and 10 years duration significantly higher GFR was seen in
patients in bad metabolic control compared to those in good control.
ERPF decreased between 2 and 10 years duration. The decrease in GFR
between 5 and 10 years might indicate an earlier onset of diabetic
nephropathy in children.
Clinical results and quality of life of old dialysis patients. L. Westlie, C.
Kjellstrand, Regional Kidney Disease Program, Hennepin Country'
Medical Center, Minneapolis, Minnesota, USA. In a prevalence study
of all 79 patients alive >70 years on in-center dialysis or home dialysis,
we evaluated morbidity, complications, biochemical results and "qual-
ity of life." Home patients (33%) had a higher creatinine. needed less
UF, had better BP control and fewer dialysis complications (0.13 vs.
0.44). More than 90% were satisfied with social contact. Fifty percent of
in-center and 30% of home patients wished to have transplants. Twenty
percent of in-center patients wanted home dialysis. Ninety percent
were outdoors when off dialysis, 52% participated in church activities,
71% enjoyed life very much. Forty-three percent felt their health was
better than other people over age 70, 70% were able to carry out normal
physical activity. Over 90% live at home. In this study aged patients
were found to be good dialysis candidates. Many can dialyze at home,
survive well, live independently, enjoy life and are surprisingly active.
Withdrawing life support: Do patients, families and physicians decide
similarly? I. E. Muwos, C. Kjellstrand, Karolinska Hospital, Stock-
ho/in, Sweden. We studied whether families and physicians decided as
patients do in discontinuation of life supporting treatment. We did so by
comparing 66 competent patients, who themselves decided to stop
dialysis to die, and 66 incompetent patients for whom families and
physicians decided. We also compared comatose to demented patients
and families' to physician's decision-making. There was no difference in
sex, diagnosis, age, time period, decision maker (family or physician),
site of residence, duration or type of dialysis, home or in-center dialysis
or survival time after discontinuation. More competent than incompe-
tent patients died at home (P < 0.005). All incompetent patients had
emerging complications, but such complications were present in only 40
of 66 competent patients (P < 0.0005). In the early 1970s the physician
initiated the termination of dialysis in all cases of incompetent patients;
in the 1980s this had decreased to 48% (P < 0.001). No case was
decided by court or hospital committee. There was no difference
between comatose or demented incompetent patients, nor was there
any important difference between family and physician decision-ma-
king. The result of our study is a reassuring indication that substitute
judgement is applied appropriately. The making of the decision can
safely and best be left to patient, family and physician.
Somatic and psychosocial prognostic indicators in chronic dialysis. D.
Ifusehy, L. West/ic, C. K/ellstrand, Universit of Minnesota,
Karolinska Hospital, Sweden. We prospectively studied the influence
of 29 demographic, social, psychological somatic factors on survival of
78 patients, aged >70 years on chronic dialysis. Three years after the
prospective evaluation, 42 patients had died. 36 survived. Only 5
factors, all psychosocial, were prognostically important. The patients
who survived rated higher on the Karnofsky scale (85 vs. 78, P <
0.002), gained less weight between dialysis (1.5 vs. 1.9 kg, P < 0.005),
were more often on home dialysis (16/36 vs. 9/42, P <0.005), less often
wished for transplantation (10/36 vs. 24/42, P < 0.01) and perceived
their health as better (3.4 vs. 3.1, p = 0.068). No somatic variable
predicted outcome. At 3 year re-interview, more patients were de-
pressed, had a lower income, fewer wanted a transplant. Five had lost
their living companion and the number of patients who cooked their
own meals, spent time outdoors, went to church or had hobbies
decreased. The Karnofsky activity decreased from 87 to 84 (P < 0.01)
and home dialysis patients' perceived health from 3.9 to 3.4 (P < 0.05).
Psychosocial but not somatic variables are prognostically important in
survival of older patients on dialysis, and there is measurable decline in
these variables during a 3-year follow-up period.
Activity of artrial natriuretic peptide in plasma before and after
hemodialysis in chronic uremic patients. L-O. Norée, U. Andersson, G.
Sylven, and E. Theodorsen-Norheim, Karo/inska institute, Renal Sec-
tion, Dept. of internal Medicine, Danderyd Hospital, Dept. of Chem-
istry, Karolinska Hospital, Stockholm, Sweden. Uremic patients main-
tained on chronic hemodialysis retaine water which must be removed
during dialysis. ANP (Atrial natriuretic peptide) is released from the
volume loaded atrium. The aim of this study was to investigate the
levels of ANP in plasma before and after dialysis. Material and
methods. Nine (mean age 49 years, range 24-76, 4 female) patients with
chronic uremia maintained on hemodialysis (Gambro AK 10, GS 120 H,
LP 105N or Travenol CA 170) for six months to fourteen years were
studied. Blood samples for determination of AN P and ADH (antiduretic
hormone) were taken before and after dialysis and analyzed by RIA.
Body weight before and after dialysis and TMP (transmembrane pres-
sure) were measured as well as routine biochemical tests monitoring
dialysis. Results. Body weight, TMP and the biochemical routine tests
in the investigated dialysis did not differ from the routine care. ANP
was 148 98 pmol/liter before dialysis and after 81 86pmot/liter. The
normal value is supposed to be less than 20 pmol/liter. ADH was 9.44
3.99 pmol/liter before dialysis and after 10.5 3.79 pmol/liter. The body
weight increased before the investigated dialysis 2.0 kg (range 0.2-2.7
kg) and decreased during the dialysis 2.0 kg (range 1.4-2.8 kg). None of
the patients had clinical signs of severe overhydration. Conclusion. The
levels of ANP in plasma were two to seventeen times higher before and
up to fifteen times higher after dialysis than in normals in spite of a
decrease in body weight during dialysis. No differences in the levels of
ADH before and after dialysis were observed.
Thiola therapy of cystinuric dogs, a treatment model for cystinuria. T.
Denneherg, M. Carlsson, A. 1-loppe, J. 0. Jeppsson. B. K2gedal,
Deportment of Medicine, Swedish University of Agriculture Sciences,
Uppsala, Departments of Nephrology and Clinical Chemistry, (Jniver-
sity Hospitals, Linkbping and Malmb, Sweden. The aim of management
of cystinuria is to keep the urinary cystine concentration less than
supersaturation, and thus to prevent cystine precipitation and stone
formation. The most promising form of therapy is to change cystine into
the more soluble mixed disulfide with D-Penicillamine or alpha-
mercaptopropionylglycine (Thiola®). D-Penicillamine is effective but
has serious side effects. We have earlier reported successful treatment
in human cystinuric patients with individualized dosages of Thiola to
patients with monitoring of free cystine and of Thiola-cysteine-disulfide
excretion in the urine. Cystinuria is a well known disease in dogs (3-27%
of all stones) with cystine excretion of 2-10 times greater than normal.
The disease occurs in many breeds and has almost exclusively been
reported in the male dog. This is the first study in dogs on
pharmacokinetics and controlled clinical effect of Thiola. Ten cystinuric
dogs were treated with Thiola for 3-34 months. The drug was well
tolerated and few side effects occurred. Pharmacokinetic studies were
determined in 8 dogs on oral administration of 16-31 mg of Thiola per kg
body weight. Maximum serum/plasma concentrations ranging from
28-76 .cmol/liter were found after 1-3 hours. The mean urinary excretion
was 22% of the dose with a range from 0.3-58%. The plasma and urine
Thiola determinations indicated that a dose interval of 12 hours would
he sufficient to maintain an adequate level of Thiola in serum and urine.
In 6 of the dogs free of stones at start of treatment no recurrence of
stones occurred. Of 4 dogs with stones appearing at the beginning of
therapy, 3 dogs experienced total stone dissolution on continuous
treatment. Further growth of the stones was inhibited in the fourth dog.
In conclusion Thiola besides prophylactic treatment could also be used
in cystine stone dissolution.
Physical working capacity in uremic patients before and after renal
transplantation. N. Clyne, T. Jogestrand, L.-E. Lins, S. K. Pehr.s.son,
Division o.t Nephrology, Cardiology, Department of Medicine arid
Department of Clinical Physiology, Korolinska Hospital, Stockholm.
Sweden. Heart disease is a major problem in the uremic population,
accounting for a large proportion of overall morbidity and mortality. In
the present longitudinal study we have examined the factors influencing
uremic patients' exercise capacity before and after renal transplanta-
tion. Eleven uremic patients (mean age 41 10 years) with an average
GFR of 5 4 before and 45 19 mI/mm )< 1.73 m2 (P < 0.001) after
transplantation participated in the study. The maximal steady-state
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exercise capacity, measured by standardized exercise test on a bicycle
ergometer, averaged 106 25 W before and 126 35 W (P < 0.05) after
transplantation. The patients interrupted because of general fatigue, leg
tiredness or both, no patient experienced angina pectoris during the
test. Normal exercise ECG were registered in 8 of II patients before
and after transplantation. Three patients had unspecific ECG-changes.
Total hemoglobin (THb) was 55 9% before and 79 14% of the
expected normal after transplantation (P < 0.01). The increase in
steady-state working capacity was correlated to the increase in THb (r
= 0.85, P < 0.01). In conclusion, successful renal transplantation
results in an improved working capacity. The results of (he present
study indicate that an increased THb may be a determinant for these
patients' increased working capacity.
CAPD performed by relalives. B. Lindqvi,si. G. Gil/nbs, K.
Lindherger. S. Lind,ström, B. Steg,navr, Departments ot Internal
Medicine, Umec, Boden, Oste,sund, Sweden. CAPD is meant to be
performed by the patients. In some cases a question arises if CAPD can
be performed by relatives. We now can report of such treatment in nine
patients, 1979-1987. Four of them were children, 4 were old or so weak
that they could not perform the treatments themselves, and I was a
slight mentally handicapped woman. The patient with the longest
treatment period so far has been two years. Technically the dialysis has
been performed with few problems. In the first years peritonite mci-
dences were reported, but the last years none. Patients so far have been
contempted with the treatment modality as well as the relatives
performing the treatment. The true mental situation of the relative
performing the dialysis is difficult to evaluate. It has, however, so far
been no signs of mental distress due to the increased responsibility. The
counties have so far been very sparse in economical support to the
relatives performing the dialysis. Compared to other active treatment
modalities this type is a cheap alternative. Economic support to the
relatives performing the dialysis is now 2500 kronor per month. Taxes
will be withdrawn. In cases where the relatives have to end regular
work, this will be an economic burden. The treatment modality seems
possible in some cases: children; patients over 70 years of age unable to
treat themselves: mentally handicapped; physically handicapped; and
old patients living far from the dialysis station. However, it should be
possible for relatives to be relieved of responsibility for a few periods
every year, and they should get greater economic support. Naturally, it
would be better to treat patients with kidney transplants in an early
stage.
Imipenem in the treatment of peritonitis during continuous ambulatory
peritoneal dialysis (CAPD). C. Eriksson, R. Brônne,stam, L. Carlsson,
A. K. Torgersen, J. A h/inc/u, Departments of of Nephrologv and Bat—
teriologv, Central Hospital, Skhvde, Sweden. Peritonitis is the most
common complication of CAPI). Imipenem is a carbapenem antibiotic
with an antibacterial spectrum covering most gram-negative and gram-
positive aero- and anaerobic bacteria. The aim of this study was to
investigate the use of imipenem in the treatment of peritonitis. Moth-
ads. imipenem/cilastatin was administered in doses of 0.5 gram or I
gram twice a day for 5 days in a four-bag dialysate exchange scheme.
Imipenem in serum was analyzed with a bioassay procedure. Antibiotic
regimen was then changed according to the results of the bacterial
culture. Cultures from dialysate were made on day 0, 2 and 5. Material.
Sixteen patients, mean age of 51.3 years at the start of CAPD, started
imipenem therapy. Seven patients had diabetic nephropathy, 3 chronic
glomerulonephropathy, 2 unspecified nephropathies and 4 patients had
other different nephropathies. Mean obs. time on CAPD was 10.6
months. All patients performed 4 x 2 liter dialysate exchanges a day.
Results. Imipenem-therapy was started in 21 peritonitis episodes.
Candida was the cause of peritonitis in 3 episodes, in 4 episodes
bacterial cultures were negative which was why the effect of imipenem
was evaluable in 14 episodes. Peritonitis was in 9 episodes caused by
Staph. epiderm., 2 Staph. aur., 2 streptococci and I by acinetobacter.
All patients recovered clinically within the imipenem-therapy period.
Relapse was only found in I patient. No clinical adverse effects of
imipenem were found in 17 peritonitis episodes. Red discoloration of
dialysate was found in a bag prepared 8 hours before intended use.
Conclusion. Imipenem may be used intraperitoneally as initial therapy
without adverse effects for 5 days with good clinical result in peritonitis
treatment during CAPD.
Clinical and experimental pruritus in chronic renal failure. M.
Backdahl, 0. Hbgerunark, L. E. Lins, Departments of Dermatology,
Medicine, Karolinska Hospital, Stockholm, Sweden. Pruritus is a
distressing manifestation of chronic renal failure. The pathogenesis of
uremic pruritus remains obscure, although dry skin, disturbed sweat-
ing, derangement of calcium homeostasis have been incriminated,
Twenty-nine patients (27-76 years) undergoing maintenance hemodial-
ysis were examined for dermatologic symptoms. Nineteen patients
(66%) complained of more or less continuous pruritus classified as mild
(34%), moderate (24%), and severe (8%). Patients with pruritus did not
differ from those without pruritus regarding serum concentrations of
creatinine, urea, calcium, alkaline phosphatase. nor was there any
difference in duration of hemodialysis. in pruritic patients serum
concentrations of parathyroid hormone were significantly higher when
determined by a mid-region radioimmunoassay technique (P < 0.01)
and higher, although not significantly, when measuring the intact
parathyroid hormone molecule. Experimental pruritus was studied by
comparing cutaneous reactions (itch and flare) following intradermat
injections of histamine in the same uremic patients with and without
pruritus and in healthy volunteers. In all uremic patients the flare
responses were weaker than in controls, whereas uremic patients with
pruritus tended to have increased itch responses indicating a decreased
itch threshold.
Blood pressure control, peripheral renin activity, plasma aldosterone
and renal hemodynamics in patients with renal scarring. S. H. Jacobson,
L.-E. Lin,s. Department of Medicine, Division of Nephrology,
Karolinska Hospital, Stock/ia/un, Sweden. Pyelonephritic renal scarring
is a common cause of hypertension and renal failure. We studied
systolic (SBP) and diastolic (DBP) blood pressure in relation to periph-
eral renin activity (PRA). plasma aldosterone (p-Aldo), urinary sodium
(UNa) and potassium (UK) excretion, fractional sodium (FeNa) and
potassium (FeK) excretion, urinary albumin excretion (U-Alb), glomer-
ular filtration rate (GFR) renal plasma flow (RPF), filtration fraction
(FF) and total renal area (TRA) in 22 female patients with renal scarring
and a history of febrile urinary tract infection and in 9 healthy
age-matched women with normal urograms. The patients had signifi-
cantly higher SBP, higher PRA. higher Fek, lower GFR and smaller
TRA. SBP and DBP were negatively correlated with GFR and RPF and
positively correlated with FeNa. The UK/UN, ratio was negatively
correlated with SBP and DBP and positively correlated with PRA and
p-Aldo. RPF/TRA representing an approximation of the perfusion of
renal tissue and GFR/TRA were similar in patients and healthy con-
trols. A reduction of renal tissue was thus accompanied by a propor-
tional decrease in GFR and RPF. Patients with a high PFR/TRA and
high GFR/TRA had lower SBP, DBP and U-Alb. We conclude that both
renal hemodynamics and the renin system probably are involved in the
pathogenesis of hypertension in patients with renal scarring and that
screening determinations of UN and UK may prove useful for detection
of individuals with increased PRA and p-Aldo. We found no evidence of
hyperfiltration by remnant glomeruli as a main cause of renal failure in
this group of patients.
Atrial natriuretic peptide (ANP) is related to blood glucose in insulin
dependent diabetes mellitus (IDDM). S. Björck, G. Blo/rmne, H. Herlitz,
J. Hedner, T. Hedner, Departments of Clinical Pharmacology, Medi-
cine II anti Nephrologv, Sahlgren.ska Hospital, llniversitv of Gdtehorg,
Sweden. In IDDM a disturbance in renal hemodynamic regulation with
an increase in glomerular filtration rate has been claimed to be impor-
tant for development of nephropathy. The role of ANP in IDDM and the
relation between glucose and ANP levels is not known. We measured
the AN P-levels in IDDM and in control patients. ANP was determined
with RIA in IS patients with IDDM (D) of II years duration and a mean
age of 26 years. and in 10 healthy control patients (C) matched for age.
ANP was 38 6(C) and 39 12 (D) pmol/liter. In the diabetic patients
the blood glucose was 12 4 mmol/liter and was positively correlated
to ANP (r = 0.69, P < 0.01). The HbAl was 10 2% and was not
related to ANP (r = 0.23). The serum-sodium concentration, which was
138 2 mmo I/I, was inversely correlated to ANP (r = 0.62, P < 0.05).
The increased level of exchangeable sodium reported in iDDM could be
antipated to induce elevation of plasma AN P-levels, hut we found no
difference in mean ANP between D and C. In addition, there was no
relationship between ANP and long-term diabetic control as reflected
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by HbAIC levels. However, the plasma-ANP was significantly corre-
lated to blood glucose. This suggests that ANP is one factor involved in
the increased glomerular filtration rate, that can be induced by acute
elevation of blood glucose in patients with IDDM. ANP may thus be of
importance for the glomerular hyperfiltration seen early in diabetes
mellitus.
Serological diagnosis of Wegener's granulomatosis. P. Bygren, N.
Rasmussen, M. Hoier-Madsen, H. Thysell, A. WOk, Nephrological
Department, University of Lund. Sweden, and Statens Seruminstitut,
Copenhagen, Denmark. Wegener's granulomatosis (WG) is a multi-
system disease with a severe prognosis. It is defined by the presence of
a focal and necrotizing vasculitis with granuloma formation, which
primarily affects vessels of the upper and lower respiratory tract. In
addition most patients develop microvasculitis in glomerular capillaries,
but the lesions found are common to a variety of glomerular disorders.
The differential diagnosis clinically includes several 'renopulmonary"
disorders, such as Goodpasture's syndrome, and systemic vasculitis.
Recently, the presence of antibodies against normal neutrophil cyto-
plasmic antigen(s) was reported in sera from patients with active WG.
Indirect immunofluorescence microscopy was used (Van der Woude, F
J et al, Lancet 1:425, 1985). Further studies strongly indicate that
ANCA assay (Anti-Neutrophil-Cytoplasmic Antibodies) can be used as
a specific immunological marker of Wegener's granulomatosis. We
analyzed sera from 15 patients given the diagnosis WG based on clinical
and histological findings. Five patients had classical granulomas and ten
had necrosis and inflammatory lesions compatible with WG. Sera from
IS controls with GN were also tested: classical periartehtis nodosa (2),
reumatoid vasculitis with GN (I), Henoch-SchOnleins purpura (I),
leucocytoclastic microvasculitis with GN (2), idiopathic rapidly pro-
gressive GN (6), saricodosis (I) and anti-GBM-induced Goodpasture
syndrome (2). In support of earlier findings, the 15 patients with
Wegener's granulomatosis had ANCA antibodies according to indirect
IF while the 15 patients with other diseases had not.
Beta-2-microglobulin (P2 M) before and after hemodialysis (HD) B.
Wehie, J. Bergstrom, Department of Renal Medicine, Karolinska
Institute, Huddinge University Hospital, Stockholm, Sweden. Patients
treated with HD for many years may develop arthropathy and carpal
tunnel syndrome due to amyloid deposits of 132 not passing through
conventional HD membranes. The observation that plasma f32M is
higher after than before HD with cuprophane has been taken as
evidence that the blood membrane contact induces an increased gen-
eration and/or release of f32M. In these studies no correction was made
for the decrease in distribution volume of f32M due to ultrafiltration, or
a correction was made only for changes in plasma volume and not for
changes in total cellular volume (ECV) which should correspond to the
distribution volume of f32M. With highly permeable membranes on the
other hand significant decreases of plasma 32M have been observed
after dialysis. In 6 patients we have studied the plasma 132M (RIA,
Pharmacia) before and after HD with 8 different dialysis membranes.
The cone after dialysis were corrected for the decrease in ECV
assuming ECV to be 20% of the body weight after dialysis (BWp) and
that the change in body weight during HD (BW), due to ultrafiltration,
represents a change in ECV according to the formula:
f32M (non corr) )< 0.2 f3Wp
0.2 /3Wp + BW
The non-corrected postdialytic j32M cone after HD with cuprophane
were 22% higher than the predialysis cone, whereas the corrected
values were not significantly changed. Similar results were obtained
with other low-permeable membranes, e.g. cellulose acetate,
polymethylmetacrylate and polycarbonate. Significant decreases of the
corrected /32M cone were observed after dialysis with high-flux mem-
branes, such as polysulphone (—47%), polyacrylonitrile (—33%) and
cellulose acetate Duo-flux (—15%). The results indicate that HD with
low-permeable membranes neither releases nor eliminates 132M, while
dialysis with high-flux membranes removes f3M.
C3b receptor (CR 1) activity on erythrocytes from patients with
systemic lupus erythematosus (SLE) followed for 2 years. E. Svarstad,
B.M. Iversen, R. Matre, Med. Dept. A and Broegelmann Research
Laboratory, University of Bergen, Bergen, Norway. CR I-receptors on
erythrocytes are probably involved in transport of immune complexes
to the reticuloendothelial system. An area of dispute is whether the
reduced CR I activity found in patients with SLE is inherited or
acquired. We have been following 8 patients with SLE and glomerulo-
nephritis for 2 years, and the CR 1 activity on the erythrocytes has been
measured repeatedly during this observation period. Three of the
patients have undergone renal transplantation, two patients within the
last 6 months, and a third 12 years ago. Four patients were clinically
stable and one patient died during the observation period. The eryth-
rocyte CR I was measured by means of a hemadsorption technique with
cryostat section of the erythrocytes and with sheep erythrocytes
sensitized with varous amount of complement as indicator cells. The
two patients who developed renal failure and were kidney transplanted
during the observation period showed increasing CR I activity after
transplantation. The patient that was transplanted 12 years earlier
showed high and stable CR I activity. One patient showed increased
activity during prednisone treatment. The clincally stable patients
showed low activity, and the patient who died also had low activity
during the observation period. Accordingly, CR I activity on erythro-
cytes seems to normalize after renal transplantation. During the active
stage of the disease, CR I activity is usually low. On treatment, some
patients may show increased CR I activity whereas most do not. The
data indicate that the low CR I activity in patients with SLE is acquired
rather than inherited.
Effect of inhibition of angiotensin converting enzyme (ACE) on the
elimination of hippuran in a patient with renal artery stenosis (RAS). E.
Svarsiad, B. M. Iversen, M. Følling, Med. Department A and Depart-
ment of Clinical Physiology, University of Bergen, Bergen, Norway.
During renal hypoperfusion ACE inhibitors can seriously disturb the
autoregulation of glomerular filtration rate (GFR) while the autoregula-
tion of renal blood flow is well preserved. In patients with RAS
treatment with ACE inhibitors may cause a fall in GFR while ERPF is
unchanged on the affected side, and thus increase the diagnostic
sensitivity of renography using Tc-DTPA as well as 131-1-Hippuran. We
have examined a 47-year-old female hypertensive with a unilateral
significant RAS. The overall renal function was normal. Treatment was
started with captopril 25 mg bid, and renography was performed after
two and four weeks and repeated three weeks after discontinuation of
captopril (control). After 64 weeks (enalapril 10 mg daily for the last 32
weeks) and 76 weeks (captopril 25 mg bid for the last 4 weeks), hippuran
renographies (H-Ren) were controlled, and ERPF (mI/mm) on the
affected side was calculated. Iv. urography (Iv-u) verified the ipsilateral
renal function.
2 wks 4 wks control 64 wks 76 wks
H-Ren accumulating normal normal normal
Iv-u normal normal
ERPF 190
(42%)
184
(37%)
183
(40%)
230
(41%)
237
(43%)
The table illustrates a temporary lack of hippuran excretion in the
affected kidney, and the isotope gradually accumluated. During control
conditions and long-term treatment, elimination was normalized.
Postrenal obstruction was excluded. These observations suggest a
possible interference of A 11 with the tubular handling of PAH in
conditions where the renin-angiotensin system is activated.
Prostaglandin E2 and 6.keto.prostaglandin F1 in nephrotic syndrome.
A. Vikse, E. DahI, 0. M. Sejersted, Department of Medicine and
Inst it ute for Experimental Medical Research, Ullevaal Hospital, Oslo,
Norway. Prostaglandin may play a role in nephrotic syndrome since
inhibition of prostaglandin synthesis by non-steriodal anti-inflammatory
drugs in some studies seem to be effective anti-proteinuric agents.
Therefore, we examined prostaglandin excretion in 10 hospitalized,
non-treated patients with nephrotic syndrome and in six normal volun-
teers. The patients were all norinotensive and creatinine clearance was
77 13 mI/mm. Urine was collected over a 24 hour period and cooled to
4°C immediately after voiding. A sample of the mixed 24-hour urine was
kept frozen for later analysis. Prostaglandins were measured by radio-
132M (corr) =
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immunoassay method after chromatographic separation on silicic acid
minicolumns. The proteinuria was 8 2 g/24 hr and prostaglandin E2
excretion 1.6 0.1 nmol/24 hr in the nephrotic patients, while 1.0 0.2
nmolI24 hr in six normal volunteers (P < 0.05). 6-Keto-prostaglandin
F was also increased in the nephrotic syndrome compared to normal
excretion, 0.8 0.1 vs. 0.5 0.1 nmol/24 hr (P < 0.05). Both
cholesterol and triglycerides were significantly increased. Peripherial
renin activity was measured only in six patients and was normal. We
propose that the increased prostaglandin excretion in nephrotic syn-
drome reflects changes in the metabolism of lipids as the precursor of
prostaglandins, arachidonic acid, derives from phospholipids.
Nephro-thyreo-arthropathia-—-A systemic disease? B. Lindqvist, U.
Dige, K. Sondell, L. Oberg, L. Jacohsson, Departments of Internal
Medicine, cytology, Blood Bank, Diagnostic Radiology and Clinical
Chemistry, Unirersity of Limed, Limed, Sweden. Fatigue and pain are
usual complaints by renal patients, especially those with interstitial
nephritis and pyelonephritis. The reason for this so called uroarthritis is
unknown. One possibility is that kidney disease in many cases is part of
a systemic disease known to give pain. Well known examples are
systemic lupus disease and patients with interstitial nephritis in Reiters
or Bechterews diseases. We believe that there are a connection even
between disease in the kidney and in the thyroid gland. Five hunded
seventy patients with kidney disease were investigated on the incidence
of S-antithyreoglobulin with a sensible technique and compared with
blood donors. Patients with high and low titers were compared there-
after. The results shows that S-antihyreoglobulin in high titer was
common in kidney patients, much more common in patients with
interstitial nephritis and pyelonephritis than in glomerulonephritis or
other kidney diseases, more common in patients with pain than in
patients without pain, more common in patients with HLA-groups 35,
27 and 8 than in other groups, and 7 times more common in women than
in men. In spite of high titers against S-antithyreoglobulin the patients
with renal disease had very seldom hyperthyreosis, hypothyreosis or
goiter. By investigation with ultrasonography 2/3 of the patients with
high titer against S-antithyreoglobulin showed light changes in the
thyroid gland. By cytological investigation after fine needle puncture of
the thyroid gland, 1/3 of the same patients had a picture of thyroiditis or
suspect thyroiditis. The investigation supports a connection between
diseases in the thyroid and the renal medulla, and that S-antithyroglob-
ulin in high titer is common in patients with renal disease and pain.
Side effects of high and low cyclosporine A (CyA) doses in patients with
rheumatoid arthritis. K. J. Berg, 0. F$rre, M. Mikkelsen. J. Narverud,
0. Djøseland, H. E. Rugstad, Rikshospitalet and Oslo Sanitetsfdren-
ings Rheumatism Hospital, Oslo, Norway. CyA was given for 26 weeks
in two groups of patients with classical arthritis (RA) and normal renal
function (S-creatinine < 110 zmoles/liter) at the following doses: Group
I CyA 10 mg/kg/day initially, mean dose 7.8 mg/kg/day (12 patients).
Group 11 CyA 5 mg/kg/day initially, mean dose 4.8 mg/kg/day (II
patients). Both groups were given prednisolone. Median whole blood
CyA concentrations after 12 weeks were 530 ag/liter (group 1) and 365
sg/liter (group 11). Median S-creatinine after 12 weeks was increased by
50% in group I (P < 0.01) and 29% in group II (P < 0.01). Creatinine
clearance was reduced by 31% in group I (P < 0.01) and 19% in group
II (P < 0.05). Mean arterial blood pressure was increased by 15% in
group I (P < 0.01) and 7% in group II (P < 0.05). S-potassium was
increased only in group 1. Renal tubular function tests (urinary beta,-
microglobulin and glandular kallikrein excretion) which were very
sensitive parameters for renal tubular damage in group I did not change
during CyA treatment in group 11. In conclusion. High CyA doses
significantly reduced renal glomerular and tubular function in patients
with RA. Low CyA doses reduced renal glomerular function far less
and was without effects on renal tubular function.
Glomerular hyperfiltration following nephrectomy in living renal trans-
plant donors. S. Strandgaard, P. Skaarup, A. Kamper. N. H. von
Holstein-Rathlou, P. P. Levssac, 0. Munck, Herlev Hospital and
Institute of Experimental Medicine, University of Copenhagen, Den-
,nark. To study the development of hyperfiltration after uninephrec-
tomy, renal clerances of Cr-EDTA, lithium and albumin, /32-microglo-
bulin and immunglobulin 0 were measured in 14 healthy living trans-
plant donors. GFR as measured by 'Cr-EDTA clerance in the kidney
that remained in the donor was 45 II (I SD) mI/mm before operation.
Five days after nephrectomy the value was 61 10 mI/mm (P < 0.01)
and remained unchanged after 2 months. Lithium clearance for the
same kidney was 12.0 4.1 mI/mm before and 24.7 13.4 mI/mm (P <
0.01) five days after removal of the other kidney. For fractional lithium
clearance the value rose from 0.25 0.07 to 0.40 0.21 (P < 0.01),
whereas absolute proximal fluid reabsorption (GFR-Cl1) was un-
changed: 35 9 mI/mm versus 37 14 mI/mm. The protein clearances
showed a rise the first 2 weeks after nephrectomy, most marked for
2-microglobulin. Our results show that after living donor nephrec-
tomy, an acute rise in GFR occurs in the remaining kidney, with no
corresponding immediate rise in proximal tubular reabsorption. Hence.
in this setting hyperfiltration may be associated with a rather marked
glomerular hypertension, possibly caused by afferent arteriolar dilata-
tion.
Long and short patency of radiocephalic arteriovenous fistulas. B.
Hylander, A. Fernstrô,n, J. Swedenhorg, Departments of Internal
Medicine and Sorgeiy, Karolinska Hospital, Stockholm, Sweden. The
aim of the study was to evaluate factors influencing patency of
arteriovenous fistulas for hemodialysis. The patency of eighty-three
radiocephalic fistulas in 71 uremic patients was analyzed retrospec-
tively. The study period was 1975—1985. Two types of fistulas were
studied according to construction: side of radial artery to side of
cephalic vein and end of cephalic vein to side of radial artery. Our
results showed that early occlusion occurred in 24 fistulas (29%). Early
occlusion was defined as occlusion before the fistula was used for
hemodialysis. Fifty-nine fistulas were thus used for dialysis. Eighteen of
these failed due to thrombosis and 41 were still open at the end of the
study period or at the time of transplantation. death, or moving to other
hospital. The cumulative patency after two years was 50%. Eleven
reoperations were performed on "early failures" and only three were
successful. Another eleven reoperations were made on "late failures".
where seven were successful. Early failure was significantly more
frequent in end-to-side fistulas (39%) compared to side-to-side fistulas
(10%). Age had no influence on the results. Out of 38 fistulas in patients
<50 years 24 were without success compared to 18 unsuccessful out of
45 fistulas in patients >50 years. Conclusion. Early failure was signif-
icantly higher in end-to-side fistulas. Reoperations on early failures are
often unsuccessful. No difference in late occlusion between the two
groups was found.
